PDF Archive

Easily share your PDF documents with your contacts, on the Web and Social Networks.

Share a file Manage my documents Convert Recover PDF Search Help Contact

Cancer Therapeutics and Supportive Care Drugs Market .pdf

Original filename: Cancer Therapeutics and Supportive Care Drugs Market.pdf
Author: user

This PDF 1.5 document has been generated by Microsoft® Word 2010, and has been sent on pdf-archive.com on 04/05/2018 at 09:07, from IP address 116.75.x.x. The current document download page has been viewed 192 times.
File size: 414 KB (6 pages).
Privacy: public file

Download original PDF file

Document preview

Cancer Therapeutics and Supportive Care Drugs Market – Global Industry Analysis,
Size, Share, Trends and Forecast, 2017 – 2023
Infinium Global Research

A latest report has been added to the wide database of Cancer Therapeutics and Supportive Care Drugs Market by Infinium
Global Research. This report studies the Cancer Therapeutics and Supportive Care Drugs Market by type (cancer
therapeutics, supportive care drugs), by distribution channel (hospital, retail) market status and outlook of global and major
regions, from manufacturers, and end industries. The objective of the study is to identify market sizes of different segments
& countries in recent years and to forecast the values for the next six years. Cancer Therapeutics and Supportive Care Drugs
Market provides opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive
landscape, latest trends, and product offerings of the major companies in the Cancer Therapeutics and Supportive Care Drugs
Market. According to the report the Global Cancer Therapeutics and Supportive Care Drugs Market is projected to grow at a
CAGR of 9.7% in terms of value over the period of 2017-2023.

The growth in the world market is primarily driven by significant contribution by North America (Leading region) region to
this market. New treatment options have become available in the past five years, and the surge of innovation is expected to
continue due to a robust pipeline of drugs in clinical development by a large and diverse group of pharmaceutical companies.
Innovations in the development of new drugs and therapies, large number of new drugs entering into the market with FDA
approval, increasing prevalence of cancerous patients, availability of new treatment options in the market and rise in base of
aging population are the key driving factors for the growth of this market. In addition, changing lifestyle habits of
populations, increased patient’s healthcare awareness, and increasing demand for non-invasive therapies are further
expected to propel the market growth in the coming years. Along with these driving factors, the market for cancer
therapeutics is facing some challenges such as time consuming regulatory compliance and high cost of cancer drugs.
However, the market for cancer therapeutics and supportive care drugs is likely to rise in the future due to the large number
of ongoing innovations for the treatment of cancer.

Geographically, North America is the leading contributor to the market and is expected to retain its position during the
forecast period due to high awareness, presence of large base of cancer patients, rise in investments, and various initiatives
by government in the healthcare sector. However, Asia-Pacific market is expected to grow at a faster rate during the forecast
period. This is predominantly due to increased healthcare awareness, technological advancements, significant investments
and growing awareness among the population about the treatment options available in the market.
Infinium Global Research

Companies profiled:
Abbott Laboratories,
AstraZeneca plc,
AstellasPharma Inc.,
Bristol-Myers Squibb,
Johnson & Johnson,
Eli Lilly,
Pfizer Inc.,
Sanofi, AbbVie, Inc.,
Teva Pharmaceuticals,
Takeda Pharmaceuticals, etc.

Report Highlights:
The report delivers a strategic analysis of the global market for cancer therapeutics and supportive care drugs and growth
forecast for the period from 2017 – 2023. The scope of the report includes competitive analysis of various market players
who are operating in the market, segmental analysis based on type. It also covers geographical analysis of the market with

Infinium Global Research

growth forecast for the period of 2017– 2023. The Porter’s Five Forces analysis and value chain analysis included in the report
provides an insight into market dynamics and industry competition.
Moreover, the report also includes growth strategies and entry barriers to be considered to cater to the exact business
opportunities in this market. Additionally, to aid in strategic decision making, the report also includes competitive profiling of
leading players, recent developments in the industry and various business strategies adopted by them. This report will help
players in global cancer therapeutics market to plan and implement their strategies in different market areas such as
emerging geographies, and new technologies.
Table of Contents:1. Scope of the Report
1.1 Report Description
1.2 Research Methodology
1.3 List of Abbreviations
1.4 Market Segmentation
2. Executive summary
3. Oncology overview
3.1 Prevalence by cancer type
3.2 New active substance launches by indication, 2011 – 2015
3.3 Oncology drugs approved in 2016
3.4 Drugs in late-phase development for various cancers
4. Qualitative Analysis
4.1 Market overview
4.1.1 Drivers
Infinium Global Research

4.1.2 Restraints
4.2 Porters five forces analysis
4.3 Competitive matrix of the key companies
4.4 Market share analysis
5. Global Cancer Therapeutics and Supportive Care Drugs Market, by Type, 2017 – 2023
5.1 Cancer Therapeutics
5.2 Supportive Care Drugs
6. Global Cancer Therapeutics and Supportive Care Drugs Market, by Distribution Channel, 2017 – 2023
6.1 Hospital
6.2 Retail
7. Global Cancer Therapeutics and Supportive Care Drugs Market, by Geography, 2017 – 2023
7.1 North America
7.2 Europe
7.2.1 Germany
7.2.2 France
7.2.3 Italy
7.2.4 UK
7.2.5 Spain
7.2.6 Others
7.3 APAC
7.3.1 China
Infinium Global Research

7.3.2 India
7.3.3 Japan
7.3.4 Others
7.4 Rest of the World
8 Company profiles
8.1 Abbott Laboratories
8.2 AstraZeneca plc
8.3 Astellas Pharma Inc.
8.4 Bristol-Myers Squibb
8.5 Johnson & Johnson
8.6 Pfizer Inc.
8.7 Novartis
8.8 Eli Lilly
8.9 Sanofi
8.10 AbbVie, Inc.
8.11 Teva Pharmaceuticals
8.12 Takeda Pharmaceuticals
Click the Below Full Report Link: https://www.infiniumglobalresearch.com/healthcare_medical_devices/cancer_therapeutics_supportive_care_drugs_mar

Infinium Global Research

Related documents

cancer therapeutics and supportive care drugs market
prostate cancer therapeutics market
antiviral drugs market
blood cancer drugs market
biological drugs market
gastric cancer drugs market

Related keywords